E-cadherin is inhibited [27–28] and N-cadherin is activated during EMT in gastric cancer [29–30], and the expression levels of the cytoskeletal protein markers β-catenin and Vimentin are also increased [31–32]. The gene discussed is CDH2; the disease is gastric cancer.